Kangmei Pharma | 600518 - Ordinary Share Capital


Kangmei Pharma reported CNY13.83B in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Genomma Lab Internacional MXN 975.03M 220K Jun/2026
Hypermarcas BRL 703.5M 64.04M Mar/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Jiangsu Hengrui CNY 6.64B 0 Jun/2026
Kangmei Pharma CNY 13.83B 0 Mar/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.61M 40K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Sh Fosun Pharma CNY 2.67B 0 Jun/2026
Tectonic Therapeutic USD 18.83M 92.19K Mar/2026
Viatris USD 1.16B 9.19M Jun/2026
Wuxi Apptec CNY 2.98B 0 Jun/2026
Xeris Pharmaceuticals USD 172.56M 6.34M Mar/2026
Zz Pientze Pharmaceu CNY 603.32M 0 Mar/2026